Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the ona domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /home/risezcom/public_html/cord-blood.org.uk/wp-includes/functions.php on line 6170
Stem Cells Help Treat Liver Failure - Cord Blood

Cord Blood

and Stem Cell Banking

Stem Cells Help Treat Liver Failure

Photo of a scientist looking at test tubes in a laboratory

Acute-on-chronic liver failure (ACLF) is a severe liver condition. In simpler terms, think of it as a sudden liver malfunction happening in someone already suffering from chronic liver issues. This can be pretty scary, as ACLF has a high mortality rate, meaning it can be fatal.

The Role of Macrophages

Our body’s inflammation responses play a significant role in the development of ACLF. Here, ‘macrophages’ are the key players. Think of macrophages as the garbage collectors of our body – they pick up waste and potential threats. However, in ACLF, they can sometimes contribute to inflammation, worsening the liver’s condition.

Hope Through Stem Cells

Now, let’s introduce the hero of our story – Mesenchymal stem cells (MSCs). These are unique cells that can differentiate into various cell types. In a previous study, it was observed that MSCs could be a potential treatment for ACLF. But how exactly? That was the mystery.

Researchers took MSCs from mouse bone marrow to treat mice with ACLF. They also conducted studies with certain types of macrophages, observing their behavior after they were stimulated.

The Big Reveal: How MSCs Help

After the study, researchers made some amazing discoveries:

  1. Improved Liver Function & Survival: Mice with ACLF treated with MSCs showed better liver function and had a higher survival rate after 48 hours.
  2. Less Inflammation: MSCs reduced inflammation. They did this by encouraging a type of ‘friendly’ macrophage behavior, known as M2 polarization.
  3. The Magic Mechanism: MSCs increased the levels of a particular protein called ‘Mertk’ in macrophages. This is exciting because Mertk is crucial in controlling the ‘friendly’ M2 macrophage behavior. And how does Mertk do this? Through a complex signaling pathway called JAK1/STAT6.

Wrapping It Up: The Future of Liver Treatment

This discovery gives a new ray of hope for those suffering from liver conditions. While it’s still in the research phase, understanding how stem cells can play a role in liver health can lead to new treatment options in the future.